A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes

Diabetes Care - United States
doi 10.2337/dc18-1760
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Cost-Efficacy of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients With Type 2 Diabetes: The EDIT Randomized Trial

PLoS ONE
Multidisciplinary
2015English

Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Feasibility and Efficacy of Nurse-Led Team Management Intervention for Improving the Self-Management of Type 2 Diabetes Patients in a Chinese Community: A Randomized Controlled Trial

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2019English

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

A Randomized, Placebo- And Sitagliptin-Controlled Trial of the Safety and Efficacy of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Japanese Patients With Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy